Found 18 matching trials
A Study to Determine the Safety and Efficacy of NT-501 With MHFM
PHASE3This study is to determine the long-term levels of CNTF, and the clinical s...
Status
Active Not Recruiting
Location
Bay Area Retina Associates, A Medical Group
NT-501 CNTF Implant for Ischemic Optic Neuropathy: Safety, Neuroprotection and Neuroenhancement
PHASE1Ciliary Neurotrophic Factor (CNTF) has been demonstrated in multiple precli...
Location
Bascom Palmer Eye Institute, University of Miami Miller School of Medicine
CNTF Implants for CNGB3 Achromatopsia
PHASE1Background:
* Achromatopsia is an inherited condition that causes vision l...
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
A Study to Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2 - Protocol A
PHASE3This study is a phase 3, randomized, multi-center study to evaluate the eff...
Location
Scripps Clinic Medical Group
Ciliary Neurotrophic Factor (CNTF) Safety Trial in Patients With Macular Telangiectasia (Mactel)
PHASE1This study is a phase 1, open label, non-randomized, multi-center, pilot st...
Location
Jules Stein Eye Institute
Retinal Imaging in CNTF -Releasing Encapsulated Cell Implant Treated Patients for Early-stage Retinitis Pigmentosa
PHASE2This clinical trial is a single-site, 30 patient study for participants who...
Location
University of California, San Francisco
Safety Study to Evaluate Bilateral CNTF Implants in Subjects With MacTel Type 2
PHASE2This is a multi-center, open-label, 6-month study to evaluate the safety of...
Location
Jules Stein Eye Institute
A Phase 2 Multicenter Randomized Clinical Trial of CNTF for MacTel
PHASE2This study is a phase 2, randomized, multi-center, single-masked study to e...
Location
Jules Stein Eye Institute
A Study of Encapsulated Cell Technology (ECT) Implant for Patients With Late Stage Retinitis Pigmentosa
PHASE2The purpose of this study is to look at the safety and effectiveness of CNT...
Location
Retina-Vitreous Associates Medical Group
Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham Procedure Participants
PHASE4The purpose of this global, multicenter, open-label, Phase 4 clinical exten...